Tylenol maker Kenvue has said that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
Midland, MI, Apr. 30--Moving forward with a long-term cost reduction plan, Dow Chemical Co. said Thursday it would cut 3,000 jobs globally this year. The announcement came as the company posted a ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
Under Armour announced a broad restructuring plan on Thursday as it said sales in its largest market, North America, plunged 10 percent and predicted the trend will get worse throughout its current ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...
Campaign US newsletters with must-read stories sent right to you. You'll also unlock limited access to valuable resources like articles, webinars, podcasts and videos on Campaignlive.com. Level up ...
(AFP) – Asian markets mostly fell Monday as a mixed jobs report eased worries about the US economy but dampened hopes for ...
SKILLMAN, N.J. - Kenvue Inc . (NYSE: NYSE:KVUE), a leading consumer health company, announced the initiation of a secondary underwritten public offering of 182,329,550 shares of its common stock today ...
Kenvue, the consumer arm spun off from healthcare group Johnson & Johnson, has added Interpublic Group’s FCB and Omnicom’s BBDO to its global agency roster. The two agencies had both previously worked ...